Explore our comprehensive portfolio that addresses the complete care continuum for many of the world’s most threatening diseases. 

    Discover the stories of pioneers pushing the boundaries of what’s possible in healthcare to help improve people’s lives around the world.

    Patient-centered innovation has been and always will be at the core of our company. Dive deeper into our fascinating technologies.

    We pioneer breakthroughs in healthcare. For everyone. Everywhere. Learn more about our purpose, our innovation leadership, our culture, and our strategy.

    1. Home

    2. Perspectives

    3. Reducing the Risk of Non-target Prostatic Artery Embolization

    Reducing the Risk of Non-target Prostatic Artery Embolization

    1min
    Published on March 24, 2018
    reducing-the-risk

     syngo DynaCT with power injection after advancing the microcatheter into the left prostatic artery distal to the vesical branches at 0.4 mL/s for 9 mL.